Common use of Retained Contracts Clause in Contracts

Retained Contracts. Amended and Restated Exclusive License Agreement The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated January 27, 2014 • Notice of Award from National Heart, Lung, and Blood Institute to Company dated August 7, 2013, revised March 4, 2014 • Institutional Review Board Authorization Agreement between Western Institutional Review Boards and Company dated December 11, 2013 • Agreement for Inter-Institutional Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated March 22, 2011 • Material Transfer Agreement (Assurance Form) for Human Cell Lines, Somatic Cell Hybrids, and DNA Samples between the ▇▇▇▇▇▇▇ Institute for Medical Research and Company dated January 29, 2014 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated January 29, 2014 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated December 7, 2013 • Material Transfer Agreement between Company and Emory University dated June 25, 2012 • Contract for Custom Wordpress Website Development between Company and bkmacdaddy designs dated August 1, 2012 • Work Order Number Immu-Alpha-01 between Compassites Software Solutions Pvt Ltd and Company dated May 28, 2011 • Nondisclosure Agreement between Company and Cloudera dated February 22, 2013 • Quote for Services letter from Company to University of Texas at Austin dated September 20, 2012 • Scientific Collaboration Agreement between Company and Fluidigm Corporation dated February 25, 2011, as amended February 22, 2012 • Sponsored Research Agreement between Molecular Medicine Research Institute and Company dated April 18, 2011, as amended June 1, 2011, June 20, 2011, December 1, 2011, February 1, 2012, February 1, 2012, June 25, 2012, December 1, 2012, and January 1, 2013 • Agreement for Services Related to Blood Components for In-Vitro Investigational Use between Company and Stanford Blood Center dated February 3, 2014 • Agreement for Services Related to Blood Components for In-Vitro Investigational Use between Company and Stanford Blood Center dated July 21, 2011 • Customer Service Agreement between Company and TriNet HR Corporation dated May 16, 2011, as amended May 10, 2011 and TriNet Services Requisition Form between Company and TriNet HR Corporation dated August 30, 2013 • Each Retained CDA SpeedVac Biosafety Hood • Laboratory Services Agreement between Company and Genentech, Inc. dated November 28, 2011 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated September 20, 2011 • Option Agreement between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated December 15, 2010 • Engagement Letter between Teknos Associates LLC and Company dated April 28, 2014 • Consulting Agreement between Company and ▇▇▇▇▇ ▇▇▇▇, Ph.D. dated October 1, 2011 • Advisory Board Agreement between Company and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ dated April 1, 2011. • Advisory Board Agreement between Company and ▇▇▇▇▇ ▇▇▇▇▇ dated March 1, 2012. • Advisory Board Agreement between Company and ▇▇▇▇ ▇▇▇▇▇, Ph.D. dated March 1, 2012. • Advisory Board Agreement between Company and ▇▇▇▇▇▇ ▇▇▇▇▇▇, dated November 1, 2010. • Advisory Board Agreement between Company and ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇, dated April 1, 2012. • Sub-lease Agreement by and between the Company and Cellular Research, Inc. dated January 15, 2013 • $ (Cash Payment Amount) • The proprietary IR software has several modules names including but not limited to: mergill, prepillrun, fdist, vdjcdr3tosql, clusterlineages, lineagetosql • An SQL database of all sample names, and relevant scientific data • A dropbox account containing the company files • software for visualizing sequencing and clustering results for non-transplant samples • Software algorithm for combining genotype and ▇▇▇▇▇▇▇▇ ▇▇▇▇ to determine the fraction of donor-derived cell-free DNA PRO United States of America 61/554,086 11/01/11 METHODS OF MONITORING THE IMMUNE SYSTEM AND RESPONSE TO TREATMENT VIA THE DETECTION OF CELL-FREE NUCLEIC ACIDS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to PCT/US2012/056416 PCT Australia ▇▇▇▇▇▇▇▇▇▇ 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT Canada 2849771 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT European Patent Convention 12834150.0 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending ORD Patent Cooperation Treaty PCT/US2012/05 6416 09/20/12 2013/043922 03/28/13 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending, 30-month done PRO United States of America 61/537,875 09/22/11 GENETIC SCREENING BY LONG-READ SEQUENCING ANALYSIS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to PCT/US2012/056416 PRO United States of America 61/608,442 03/08/12 GENETIC SCREENING BY LONG-READ SEQUENCING ANALYSIS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to ▇▇▇/▇▇▇▇▇▇/▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ of America 14/346,293 03/20/14 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT Australia 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT Canada 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT China (People’s Republic) 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT European Patent Convention 12778840.4 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT Japan 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending ORD Patent Cooperation Treaty PCT/US2012/056911 09/24/12 13/044234 03/28/13 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE HUTCHINS, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ National ORD United States of America 13/625645 09/24/12 2013-0078633 03/28/13 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE HUTCHINS, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Published ORD Patent Cooperation Treaty PCT/US2014/029241 03/14/14 METHODS OF SEQUENCING THE IMMUNE REPERTOIRE FAN, C.; ▇▇▇▇▇▇▇▇, E. Pending ORD Patent Cooperation Treaty PCT/US2014/029393 03/14/14 METHODS AND COMPOSITIONS FOR TAGGING AND ANALYZING SAMPLES FAN, C.; ▇▇▇▇▇▇▇▇, E. Pending • Invention Disclosure describing invention titled “Absolute Quantitation and Sample Processing Quality Control Using Barcoded DNA Oligos” dated April 22, 2014 with ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and ▇▇▇▇ Sit listed as inventors • Invention Disclosure describing invention titled “Absolute Quantitation by Sequencing of Donor DNA in Organ Transplant Recipients” with ▇▇▇▇▇▇ ▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “The Use of Convergent Antibody Evolution as a means to detect the onset of disease” with ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “Differential Diagnosis of the Origin of Graft Injury using Size Profiling of Donor DNA Molecules” with ▇▇▇▇▇▇ ▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “Improved Absolute Quantitation and Sample Processing Quality Control Using Barcoded DNA Oligos” dated May 15, 2014 with ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ listed as inventor

Retained Contracts. Amended and Restated Exclusive License Agreement The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated January 27, 2014 • Notice of Award from National Heart, Lung, and Blood Institute to Company dated August 7, 2013, revised March 4, 2014 • Institutional Review Board Authorization Agreement between Western Institutional Review Boards and Company dated December 11, 2013 • Agreement for Inter-Institutional Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated March 22, 2011 • Material Transfer Agreement (Assurance Form) for Human Cell Lines, Somatic Cell Hybrids, and DNA Samples between the ▇▇▇▇▇▇▇ Institute for Medical Research and Company dated January 29, 2014 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated January 29, 2014 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated December 7, 2013 • Material Transfer Agreement between Company and Emory University dated June 25, 2012 • Contract for Custom Wordpress Website Development between Company and bkmacdaddy designs dated August 1, 2012 • Work Order Number Immu-Alpha-01 between Compassites Software Solutions Pvt Ltd and Company dated May 28, 2011 • Nondisclosure Agreement between Company and Cloudera dated February 22, 2013 • Quote for Services letter from Company to University of Texas at Austin dated September 20, 2012 • Scientific Collaboration Agreement between Company and Fluidigm Corporation dated February 25, 2011, as amended February 22, 2012 • Sponsored Research Agreement between Molecular Medicine Research Institute and Company dated April 18, 2011, as amended June 1, 2011, June 20, 2011, December 1, 2011, February 1, 2012, February 1, 2012, June 25, 2012, December 1, 2012, and January 1, 2013 • Agreement for Services Related to Blood Components for In-Vitro Investigational Use between Company and Stanford Blood Center dated February 3, 2014 • Agreement for Services Related to Blood Components for In-Vitro Investigational Use between Company and Stanford Blood Center dated July 21, 2011 • Customer Service Agreement between Company and TriNet HR Corporation dated May 16, 2011, as amended May 10, 2011 and TriNet Services Requisition Form between Company and TriNet HR Corporation dated August 30, 2013 • Each Retained CDA SpeedVac Biosafety Hood • Laboratory Services Agreement between Company and Genentech, Inc. dated November 28, 2011 • Agreement for Transfer of Human Tissue Samples between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated September 20, 2011 • Option Agreement between The Board of Trustees of the ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Junior University and Company dated December 15, 2010 • Engagement Letter between Teknos Associates LLC and Company dated April 28, 2014 • Consulting Agreement between Company and ▇▇▇▇▇ ▇▇▇▇, Ph.D. dated October 1, 2011 • Advisory Board Agreement between Company and ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ dated April 1, 2011. • Advisory Board Agreement between Company and ▇▇▇▇▇ ▇▇▇▇▇ dated March 1, 2012. • Advisory Board Agreement between Company and ▇▇▇▇ ▇▇▇▇▇, Ph.D. dated March 1, 2012. • Advisory Board Agreement between Company and ▇▇▇▇▇▇ ▇▇▇▇▇▇, dated November 1, 2010. • Advisory Board Agreement between Company and ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇, dated April 1, 2012. • Sub-lease Agreement by and between the Company and Cellular Research, Inc. dated January 15, 2013 • $ (Cash Payment Amount) • The proprietary IR software has several modules names including but not limited to: mergill, prepillrun, fdist, vdjcdr3tosql, clusterlineages, lineagetosql • An SQL database of all sample names, and relevant scientific data • A dropbox account containing the company files • software for visualizing sequencing and clustering results for non-transplant samples • Software algorithm for combining genotype and ▇▇▇▇▇▇▇▇ ▇▇▇▇ to determine the fraction of donor-derived cell-free DNA PRO United States of America 61/554,086 11/01/11 METHODS OF MONITORING THE IMMUNE SYSTEM AND RESPONSE TO TREATMENT VIA THE DETECTION OF CELL-FREE NUCLEIC ACIDS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to PCT/US2012/056416 PCT Australia ▇▇▇▇▇▇▇▇▇▇ 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT Canada 2849771 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT European Patent Convention 12834150.0 09/20/12 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending ORD Patent Cooperation Treaty PCT/US2012/05 6416 09/20/12 2013/043922 03/28/13 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending, 30-month done PRO United States of America 61/537,875 09/22/11 GENETIC SCREENING BY LONG-READ SEQUENCING ANALYSIS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to PCT/US2012/056416 PRO United States of America 61/608,442 03/08/12 GENETIC SCREENING BY LONG-READ SEQUENCING ANALYSIS ▇▇▇▇▇▇▇▇, ▇▇▇ Converted to ▇▇▇/▇▇▇▇▇▇/▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ of America 14/346,293 03/20/14 COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES ▇▇▇▇▇▇▇▇, ▇▇▇; ▇▇▇▇▇▇, ▇▇▇▇▇▇ Pending PCT Australia 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT Canada 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT China (People’s Republic) 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT European Patent Convention 12778840.4 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending PCT Japan 09/24/12 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE ▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Pending ORD Patent Cooperation Treaty PCT/US2012/056911 09/24/12 13/044234 03/28/13 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE HUTCHINS, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ National ORD United States of America 13/625645 09/24/12 2013-0078633 03/28/13 DETECTION OF ISOTYPE PROFILES AS SIGNATURES FOR DISEASE HUTCHINS▇▇▇▇▇▇▇▇, M.; ▇▇▇▇▇▇▇▇, ▇▇▇ Published ORD Patent Cooperation Treaty PCT/US2014/029241 03/14/14 METHODS OF SEQUENCING THE IMMUNE REPERTOIRE FAN, C.; ▇▇▇▇▇▇▇▇, E. Pending ORD Patent Cooperation Treaty PCT/US2014/029393 03/14/14 METHODS AND COMPOSITIONS FOR TAGGING AND ANALYZING SAMPLES FAN, C.; ▇▇▇▇▇▇▇▇, E. Pending • Invention Disclosure describing invention titled “Absolute Quantitation and Sample Processing Quality Control Using Barcoded DNA Oligos” dated April 22, 2014 with ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ and ▇▇▇▇ Sit listed as inventors • Invention Disclosure describing invention titled “Absolute Quantitation by Sequencing of Donor DNA in Organ Transplant Recipients” with ▇▇▇▇▇▇ ▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “The Use of Convergent Antibody Evolution as a means to detect the onset of disease” with ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “Differential Diagnosis of the Origin of Graft Injury using Size Profiling of Donor DNA Molecules” with ▇▇▇▇▇▇ ▇▇▇▇▇▇ listed as inventor • Invention Disclosure describing invention titled “Improved Absolute Quantitation and Sample Processing Quality Control Using Barcoded DNA Oligos” dated May 15, 2014 with ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ listed as inventor